Bluebird bio Inc (NASDAQ: BLUE): The Best-Of-Breed For Investing?
BlackRock Fund Advisors recently announced the acquisition of new stake in Bluebird bio Inc (NASDAQ:BLUE). The institutional investor has increased its shareholding in the Healthcare company by 0.89% to 7.81 million shares with purchase of 69040.0 shares. This fresh investment now brings its stake to 7.14% valued currently at $29.84 million. In addition, The Vanguard […]
Bluebird bio Inc (BLUE): Street Finally Waking Up
BlackRock Fund Advisors recently announced the acquisition of new stake in Bluebird bio Inc (NASDAQ:BLUE). The institutional investor has increased its shareholding in the Healthcare company by 0.89% to 7.81 million shares with purchase of 69040.0 shares. This fresh investment now brings its stake to 7.14% valued currently at $29.84 million. In addition, The Vanguard […]
